Imaging modalities

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Benign focal liver lesions, including cysts, hemangiomas, and focal nodular hyperplasia, are common. Annually, many patients worldwide undergo imaging for the work-up of a suspected or known abnormality of the liver. Cross-sectional imaging modalities, such as US, CT, and MR imaging, are used in most centers to assess liver abnormalities. These modalities, often used in various combinations, have fundamental differences in data acquisition and hence differences in the type of physical characteristics of tissues they interrogate. Currently, there is no consensus concerning the optimal strategy for liver imaging. Imaging modalities are often used based on the requests of referring physicians and the availability of equipment and experience of the radiologists. Most centers use US, CT, and CT-guided biopsy; MR imaging is often used as a problem-solving modality. The main goals of imaging are to assess (1) the nature of the lesions, (2) the number and size of liver abnormalities, and (3) the location of abnormalities relative to the vessels. All these aspects influence clinical and surgical decision making. This chapter describes a number of aspects of liver imaging including the current status and recent development of ultrasound, CT, and MR imaging and the role of these imaging modalities in the assessment of benign hepatic abnormalities.

Original languageEnglish
Title of host publicationBenign Tumors of the Liver
PublisherSpringer International Publishing
Pages49-60
Number of pages12
ISBN (Print)9783319129853, 9783319129846
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Imaging techniques
Liver
Focal Nodular Hyperplasia
Hemangioma
Cysts
Consensus
Biopsy
Physicians
Equipment and Supplies
Data acquisition
Ultrasonics
Decision making
Availability
Tissue

Keywords

  • Benign liver lesions
  • Computed tomography
  • Imaging modalities
  • Magnetic resonance
  • Ultrasound

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

De Cobelli, F., Ironi, G., Marra, P., Esposito, A., & Del Maschio, A. (2015). Imaging modalities. In Benign Tumors of the Liver (pp. 49-60). Springer International Publishing. https://doi.org/10.1007/978-3-319-12985-3_5

Imaging modalities. / De Cobelli, Francesco; Ironi, Gabriele; Marra, Paolo; Esposito, Antonio; Del Maschio, Alessandro.

Benign Tumors of the Liver. Springer International Publishing, 2015. p. 49-60.

Research output: Chapter in Book/Report/Conference proceedingChapter

De Cobelli, F, Ironi, G, Marra, P, Esposito, A & Del Maschio, A 2015, Imaging modalities. in Benign Tumors of the Liver. Springer International Publishing, pp. 49-60. https://doi.org/10.1007/978-3-319-12985-3_5
De Cobelli F, Ironi G, Marra P, Esposito A, Del Maschio A. Imaging modalities. In Benign Tumors of the Liver. Springer International Publishing. 2015. p. 49-60 https://doi.org/10.1007/978-3-319-12985-3_5
De Cobelli, Francesco ; Ironi, Gabriele ; Marra, Paolo ; Esposito, Antonio ; Del Maschio, Alessandro. / Imaging modalities. Benign Tumors of the Liver. Springer International Publishing, 2015. pp. 49-60
@inbook{697c4f025f6e407c8547bc07adf1f4dc,
title = "Imaging modalities",
abstract = "Benign focal liver lesions, including cysts, hemangiomas, and focal nodular hyperplasia, are common. Annually, many patients worldwide undergo imaging for the work-up of a suspected or known abnormality of the liver. Cross-sectional imaging modalities, such as US, CT, and MR imaging, are used in most centers to assess liver abnormalities. These modalities, often used in various combinations, have fundamental differences in data acquisition and hence differences in the type of physical characteristics of tissues they interrogate. Currently, there is no consensus concerning the optimal strategy for liver imaging. Imaging modalities are often used based on the requests of referring physicians and the availability of equipment and experience of the radiologists. Most centers use US, CT, and CT-guided biopsy; MR imaging is often used as a problem-solving modality. The main goals of imaging are to assess (1) the nature of the lesions, (2) the number and size of liver abnormalities, and (3) the location of abnormalities relative to the vessels. All these aspects influence clinical and surgical decision making. This chapter describes a number of aspects of liver imaging including the current status and recent development of ultrasound, CT, and MR imaging and the role of these imaging modalities in the assessment of benign hepatic abnormalities.",
keywords = "Benign liver lesions, Computed tomography, Imaging modalities, Magnetic resonance, Ultrasound",
author = "{De Cobelli}, Francesco and Gabriele Ironi and Paolo Marra and Antonio Esposito and {Del Maschio}, Alessandro",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-12985-3_5",
language = "English",
isbn = "9783319129853",
pages = "49--60",
booktitle = "Benign Tumors of the Liver",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Imaging modalities

AU - De Cobelli, Francesco

AU - Ironi, Gabriele

AU - Marra, Paolo

AU - Esposito, Antonio

AU - Del Maschio, Alessandro

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Benign focal liver lesions, including cysts, hemangiomas, and focal nodular hyperplasia, are common. Annually, many patients worldwide undergo imaging for the work-up of a suspected or known abnormality of the liver. Cross-sectional imaging modalities, such as US, CT, and MR imaging, are used in most centers to assess liver abnormalities. These modalities, often used in various combinations, have fundamental differences in data acquisition and hence differences in the type of physical characteristics of tissues they interrogate. Currently, there is no consensus concerning the optimal strategy for liver imaging. Imaging modalities are often used based on the requests of referring physicians and the availability of equipment and experience of the radiologists. Most centers use US, CT, and CT-guided biopsy; MR imaging is often used as a problem-solving modality. The main goals of imaging are to assess (1) the nature of the lesions, (2) the number and size of liver abnormalities, and (3) the location of abnormalities relative to the vessels. All these aspects influence clinical and surgical decision making. This chapter describes a number of aspects of liver imaging including the current status and recent development of ultrasound, CT, and MR imaging and the role of these imaging modalities in the assessment of benign hepatic abnormalities.

AB - Benign focal liver lesions, including cysts, hemangiomas, and focal nodular hyperplasia, are common. Annually, many patients worldwide undergo imaging for the work-up of a suspected or known abnormality of the liver. Cross-sectional imaging modalities, such as US, CT, and MR imaging, are used in most centers to assess liver abnormalities. These modalities, often used in various combinations, have fundamental differences in data acquisition and hence differences in the type of physical characteristics of tissues they interrogate. Currently, there is no consensus concerning the optimal strategy for liver imaging. Imaging modalities are often used based on the requests of referring physicians and the availability of equipment and experience of the radiologists. Most centers use US, CT, and CT-guided biopsy; MR imaging is often used as a problem-solving modality. The main goals of imaging are to assess (1) the nature of the lesions, (2) the number and size of liver abnormalities, and (3) the location of abnormalities relative to the vessels. All these aspects influence clinical and surgical decision making. This chapter describes a number of aspects of liver imaging including the current status and recent development of ultrasound, CT, and MR imaging and the role of these imaging modalities in the assessment of benign hepatic abnormalities.

KW - Benign liver lesions

KW - Computed tomography

KW - Imaging modalities

KW - Magnetic resonance

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84944597675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944597675&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12985-3_5

DO - 10.1007/978-3-319-12985-3_5

M3 - Chapter

AN - SCOPUS:84944597675

SN - 9783319129853

SN - 9783319129846

SP - 49

EP - 60

BT - Benign Tumors of the Liver

PB - Springer International Publishing

ER -